Life Science News
Latest updates from the biotech and pharma world
A Look At The Fair Value Of Agilent Technologies, Inc. (NYSE:A) - Yahoo Finance
4 takeaways from pharma’s manufacturing boom
Morgan Stanley upgrades Lonza, citing valuation support ahead of 2026 guide - Investing.com
Agilent Technologies disappoints with new earnings forecast - medwatch.com
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com Nigeria
Novartis was the sole bidder in $12B deal to buy Avidity
#Avidity Biosciences#buy Avidity#chief executives#billion agreement#sole bidder
Switzerland: Microsize and Schedio Group to acquire Lonza’s Micro-Macinazione site in Switzerland - Investors in Healthcare
#Schedio Group#acquire Lonza#Micro-Macinazione site#Healthcare Switzerland#Switzerland Investors
Agilent Technologies (A) Exceeds Q4 Revenue Expectations with St - GuruFocus
#Revenue Expectations#Agilent Technologies#Exceeds#Technologies#Revenue
Thermo Fisher Scientific prices €2.1B euro-denominated senior notes offering - MSN
The Zacks Analyst Blog Highlights Alphabet, Roche, RTX, Crawford United and C&F Financial - Nasdaq
Thermo Fisher Inaugurates Customer Experience and Bioprocess Centre’s in Hyderabad - Chemical Industry Digest
#Fisher Inaugurates#Inaugurates Customer#Customer Experience#Bioprocess Centre#Chemical Industry
Thermo Fisher Scientific prices €2.1B euro-denominated senior notes offering - MSN
#Fisher Scientific#Scientific prices#Thermo Fisher#euro-denominated senior#senior notes
Lonza Group Ltd: Strong Growth Prospects and Attractive Valuation Support Buy Rating - TipRanks
#Strong Growth#Growth Prospects#Attractive Valuation#Valuation Support#Support Buy
Agilent Technology Q4 Earnings Improve, Expects 6% To 8% Revenue Growth In Q1 - Nasdaq
#Earnings Improve#Revenue Growth#Agilent Technology#Nasdaq Agilent#Expects
Morgan Stanley upgrades Lonza Group stock to Overweight on growth outlook - Investing.com India
#Lonza Group#Investing.com India#Morgan Stanley#Stanley upgrades#upgrades Lonza
David Roche expects controlled market correction in next six months - The Economic Times
#Economic Times#David Roche#Roche expects#expects controlled#controlled market
Agilent Technologies Inc (A) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - Yahoo Finance
#Earnings Call#Call Highlights#Strong Revenue#Growth Amidst#Revenue Growth
Are Thermo Fisher Shares a Fair Deal After Key Pharma Partnerships and 14% Price Surge? - Yahoo Finance
#Price Surge#Thermo Fisher#Fisher Shares#Fair Deal#Key Pharma
Thermo Fisher prices €2.1 billion notes offering in two tranches - Investing.com
#Fisher prices#Thermo Fisher#billion notes#notes offering#Investing.com Thermo